The New Nation - Internet Edition

The ACME Laboratories Ltd has recently launched sustained release formulation of Tramadol HCL as DOLONIL SR tablet 100 mg.

DOLONIL SR tablet is the first manufactured sustained release formulation of Tramadol HCI in Bangladesh. It is a potential pain killer and is indicated in post-operative pain, traumas and fractures, musculoskeletal pain, neurogenic pain, cancer pain etc.

DOLONIL is a centrally acting synthetic opioid analgesic with fewer side effects. It is as effective as pethidine with reduced respiratory depression, sedation and constipation. DOLONIL SR tablet minimises the dosing frequency as it requires to be taken twice daily whether immediate release formulation of Tramadol HCI requires 4-6 times daily for complete therapeutic action. It is currently available in SR tablet, capsule and injection form. Each box of DOLONIL SR tablet contains 16 tablets (2 x 8's) in blister strips and price is Tk 14 per tablet.